Advertisement

Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib

Richard D. Press, Stephanie G. Willis, Jennifer Laudadio, Michael J. Mauro, Michael W. N. Deininger
PDF Container